Pyrogallol

Pyrogallol

SCHEMBL901411

Oc1cccc(O)c1O.Oc1ccccc1C(c1ccccc1O)c1ccccc1O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.60
HPGD P15428 4/20 0.60
CA2 P00918 3/20 0.60
ALDH1A1 P00352 3/20 0.60
ALOX15 P16050 3/20 0.60
HSD17B10 Q99714 3/20 0.60
EGFR P00533 2/20 0.60
FYN P06241 2/20 0.60
MMP9 P14780 2/20 0.60
RECQL P46063 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
CA1 P00915 2/20 0.60
ADAMTS4 O75173 1/20 0.60
MMP2 P08253 1/20 0.60
MMP8 P22894 1/20 0.60
CA6 P23280 1/20 0.60
CDK2 P24941 1/20 0.60
MMP12 P39900 1/20 0.60
ADAMTS5 Q9UNA0 1/20 0.60
GABRA1 P14867 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9811611 0.93 LMNA (0.50) LMNAHPGDCA2ALDH1A1ALOX15
SCHEMBL7160136 0.93 LMNA (0.50) LMNAHPGDCA2ALDH1A1ALOX15
SCHEMBL78917 0.89 GABRA1 (0.62) LMNAHPGDCA2ALDH1A1ALOX15
SCHEMBL29407501 0.89 GABRA1 (0.62) LMNAHPGDCA2ALDH1A1ALOX15
SCHEMBL4061536 0.87 GABRA1 (0.59) LMNAHPGDCA2ALDH1A1ALOX15
Phenol SCHEMBL10682421 0.80 TDP1 (0.55) LMNAHPGDCA2ALDH1A1ALOX15
SCHEMBL10789588 0.79 GABRA1 (0.52) LMNAHPGDCA2ALDH1A1ALOX15
Pyrogallol SCHEMBL1668793 0.78 ALDH1A1 (0.86) LMNAHPGDCA2ALDH1A1ALOX15
Pyrogallol SCHEMBL170157 0.78 ALDH1A1 (1.00) LMNAHPGDCA2ALDH1A1ALOX15
Pyrogallol SCHEMBL3532 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284434-B2 Epoxy resin compositions BLUE CUBE IP LLC (US) 2016-03-15 US disclosed
US-20140194554-A1 EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-10 US disclosed
US-20130302336-A1 DISULFIDE STABILIZED DVD-IG MOLECULES UCB PHARMA S.A. (BE) 2013-11-14 US disclosed
EP-2621994-A1 EPOXY RESIN COMPOSITIONS Dow Global Technologies LLC (US) 2013-08-07 EP disclosed
WO-2012044443-A1 EPOXY RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130302336-A1 DISULFIDE STABILIZED DVD-IG MOLECULES EED, DRD2, PSMD14 LMNA 4838/4885HPGD 191/4885CA2 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.